Global Hospital-Acquired Infection Control Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Hospital-Acquired Infection Control market size was valued at USD 5867.2 million in 2023 and is forecast to a readjusted size of USD 7101.9 million by 2030 with a CAGR of 2.8% during review period.

HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission.

HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Hospital-Acquired Infection Control industry chain, the market status of Hospitals and ICUs (Catheter-associated Urinary Tract Infections (CAUTIs), Surgical Site Infections (SSIs)), Outpatient Care Centers (Catheter-associated Urinary Tract Infections (CAUTIs), Surgical Site Infections (SSIs)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-Acquired Infection Control.

Regionally, the report analyzes the Hospital-Acquired Infection Control markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-Acquired Infection Control market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Hospital-Acquired Infection Control market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-Acquired Infection Control industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Catheter-associated Urinary Tract Infections (CAUTIs), Surgical Site Infections (SSIs)).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-Acquired Infection Control market.

Regional Analysis: The report involves examining the Hospital-Acquired Infection Control market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-Acquired Infection Control market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Hospital-Acquired Infection Control:
Company Analysis: Report covers individual Hospital-Acquired Infection Control players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-Acquired Infection Control This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and ICUs, Outpatient Care Centers).

Technology Analysis: Report covers specific technologies relevant to Hospital-Acquired Infection Control. It assesses the current state, advancements, and potential future developments in Hospital-Acquired Infection Control areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-Acquired Infection Control market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Hospital-Acquired Infection Control market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Catheter-associated Urinary Tract Infections (CAUTIs)
    Surgical Site Infections (SSIs)
    Central Line-associated Bloodstream Infections (CLABSIs)
    Respiratory Infections

Market segment by Application
    Hospitals and ICUs
    Outpatient Care Centers
    Long-term Care Facilities (LTCFs)

Market segment by players, this report covers
    GSK
    Merck
    Pfizer
    3M
    Abbott
    BD
    Cepheid
    Getinge Group

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hospital-Acquired Infection Control product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-Acquired Infection Control, with revenue, gross margin and global market share of Hospital-Acquired Infection Control from 2019 to 2024.
Chapter 3, the Hospital-Acquired Infection Control competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-Acquired Infection Control market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Infection Control.
Chapter 13, to describe Hospital-Acquired Infection Control research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Hospital-Acquired Infection Control
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Hospital-Acquired Infection Control by Type
        1.3.1 Overview: Global Hospital-Acquired Infection Control Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Hospital-Acquired Infection Control Consumption Value Market Share by Type in 2023
        1.3.3 Catheter-associated Urinary Tract Infections (CAUTIs)
        1.3.4 Surgical Site Infections (SSIs)
        1.3.5 Central Line-associated Bloodstream Infections (CLABSIs)
        1.3.6 Respiratory Infections
    1.4 Global Hospital-Acquired Infection Control Market by Application
        1.4.1 Overview: Global Hospital-Acquired Infection Control Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals and ICUs
        1.4.3 Outpatient Care Centers
        1.4.4 Long-term Care Facilities (LTCFs)
    1.5 Global Hospital-Acquired Infection Control Market Size & Forecast
    1.6 Global Hospital-Acquired Infection Control Market Size and Forecast by Region
        1.6.1 Global Hospital-Acquired Infection Control Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Hospital-Acquired Infection Control Market Size by Region, (2019-2030)
        1.6.3 North America Hospital-Acquired Infection Control Market Size and Prospect (2019-2030)
        1.6.4 Europe Hospital-Acquired Infection Control Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Hospital-Acquired Infection Control Market Size and Prospect (2019-2030)
        1.6.6 South America Hospital-Acquired Infection Control Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Hospital-Acquired Infection Control Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Hospital-Acquired Infection Control Product and Solutions
        2.1.4 GSK Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 GSK Recent Developments and Future Plans
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Hospital-Acquired Infection Control Product and Solutions
        2.2.4 Merck Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Merck Recent Developments and Future Plans
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Hospital-Acquired Infection Control Product and Solutions
        2.3.4 Pfizer Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Pfizer Recent Developments and Future Plans
    2.4 3M
        2.4.1 3M Details
        2.4.2 3M Major Business
        2.4.3 3M Hospital-Acquired Infection Control Product and Solutions
        2.4.4 3M Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 3M Recent Developments and Future Plans
    2.5 Abbott
        2.5.1 Abbott Details
        2.5.2 Abbott Major Business
        2.5.3 Abbott Hospital-Acquired Infection Control Product and Solutions
        2.5.4 Abbott Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Abbott Recent Developments and Future Plans
    2.6 BD
        2.6.1 BD Details
        2.6.2 BD Major Business
        2.6.3 BD Hospital-Acquired Infection Control Product and Solutions
        2.6.4 BD Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 BD Recent Developments and Future Plans
    2.7 Cepheid
        2.7.1 Cepheid Details
        2.7.2 Cepheid Major Business
        2.7.3 Cepheid Hospital-Acquired Infection Control Product and Solutions
        2.7.4 Cepheid Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Cepheid Recent Developments and Future Plans
    2.8 Getinge Group
        2.8.1 Getinge Group Details
        2.8.2 Getinge Group Major Business
        2.8.3 Getinge Group Hospital-Acquired Infection Control Product and Solutions
        2.8.4 Getinge Group Hospital-Acquired Infection Control Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Getinge Group Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Hospital-Acquired Infection Control Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Hospital-Acquired Infection Control by Company Revenue
        3.2.2 Top 3 Hospital-Acquired Infection Control Players Market Share in 2023
        3.2.3 Top 6 Hospital-Acquired Infection Control Players Market Share in 2023
    3.3 Hospital-Acquired Infection Control Market: Overall Company Footprint Analysis
        3.3.1 Hospital-Acquired Infection Control Market: Region Footprint
        3.3.2 Hospital-Acquired Infection Control Market: Company Product Type Footprint
        3.3.3 Hospital-Acquired Infection Control Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Hospital-Acquired Infection Control Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Hospital-Acquired Infection Control Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Hospital-Acquired Infection Control Consumption Value Market Share by Application (2019-2024)
    5.2 Global Hospital-Acquired Infection Control Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Hospital-Acquired Infection Control Consumption Value by Type (2019-2030)
    6.2 North America Hospital-Acquired Infection Control Consumption Value by Application (2019-2030)
    6.3 North America Hospital-Acquired Infection Control Market Size by Country
        6.3.1 North America Hospital-Acquired Infection Control Consumption Value by Country (2019-2030)
        6.3.2 United States Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        6.3.3 Canada Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        6.3.4 Mexico Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Hospital-Acquired Infection Control Consumption Value by Type (2019-2030)
    7.2 Europe Hospital-Acquired Infection Control Consumption Value by Application (2019-2030)
    7.3 Europe Hospital-Acquired Infection Control Market Size by Country
        7.3.1 Europe Hospital-Acquired Infection Control Consumption Value by Country (2019-2030)
        7.3.2 Germany Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        7.3.3 France Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        7.3.5 Russia Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        7.3.6 Italy Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Hospital-Acquired Infection Control Market Size by Region
        8.3.1 Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Region (2019-2030)
        8.3.2 China Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        8.3.3 Japan Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        8.3.4 South Korea Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        8.3.5 India Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        8.3.7 Australia Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Hospital-Acquired Infection Control Consumption Value by Type (2019-2030)
    9.2 South America Hospital-Acquired Infection Control Consumption Value by Application (2019-2030)
    9.3 South America Hospital-Acquired Infection Control Market Size by Country
        9.3.1 South America Hospital-Acquired Infection Control Consumption Value by Country (2019-2030)
        9.3.2 Brazil Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        9.3.3 Argentina Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Hospital-Acquired Infection Control Market Size by Country
        10.3.1 Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Country (2019-2030)
        10.3.2 Turkey Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)
        10.3.4 UAE Hospital-Acquired Infection Control Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Hospital-Acquired Infection Control Market Drivers
    11.2 Hospital-Acquired Infection Control Market Restraints
    11.3 Hospital-Acquired Infection Control Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Hospital-Acquired Infection Control Industry Chain
    12.2 Hospital-Acquired Infection Control Upstream Analysis
    12.3 Hospital-Acquired Infection Control Midstream Analysis
    12.4 Hospital-Acquired Infection Control Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hospital-Acquired Infection Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Hospital-Acquired Infection Control Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Hospital-Acquired Infection Control Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Hospital-Acquired Infection Control Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. GSK Company Information, Head Office, and Major Competitors
    Table 6. GSK Major Business
    Table 7. GSK Hospital-Acquired Infection Control Product and Solutions
    Table 8. GSK Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. GSK Recent Developments and Future Plans
    Table 10. Merck Company Information, Head Office, and Major Competitors
    Table 11. Merck Major Business
    Table 12. Merck Hospital-Acquired Infection Control Product and Solutions
    Table 13. Merck Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Merck Recent Developments and Future Plans
    Table 15. Pfizer Company Information, Head Office, and Major Competitors
    Table 16. Pfizer Major Business
    Table 17. Pfizer Hospital-Acquired Infection Control Product and Solutions
    Table 18. Pfizer Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Pfizer Recent Developments and Future Plans
    Table 20. 3M Company Information, Head Office, and Major Competitors
    Table 21. 3M Major Business
    Table 22. 3M Hospital-Acquired Infection Control Product and Solutions
    Table 23. 3M Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. 3M Recent Developments and Future Plans
    Table 25. Abbott Company Information, Head Office, and Major Competitors
    Table 26. Abbott Major Business
    Table 27. Abbott Hospital-Acquired Infection Control Product and Solutions
    Table 28. Abbott Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Abbott Recent Developments and Future Plans
    Table 30. BD Company Information, Head Office, and Major Competitors
    Table 31. BD Major Business
    Table 32. BD Hospital-Acquired Infection Control Product and Solutions
    Table 33. BD Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. BD Recent Developments and Future Plans
    Table 35. Cepheid Company Information, Head Office, and Major Competitors
    Table 36. Cepheid Major Business
    Table 37. Cepheid Hospital-Acquired Infection Control Product and Solutions
    Table 38. Cepheid Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Cepheid Recent Developments and Future Plans
    Table 40. Getinge Group Company Information, Head Office, and Major Competitors
    Table 41. Getinge Group Major Business
    Table 42. Getinge Group Hospital-Acquired Infection Control Product and Solutions
    Table 43. Getinge Group Hospital-Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Getinge Group Recent Developments and Future Plans
    Table 45. Global Hospital-Acquired Infection Control Revenue (USD Million) by Players (2019-2024)
    Table 46. Global Hospital-Acquired Infection Control Revenue Share by Players (2019-2024)
    Table 47. Breakdown of Hospital-Acquired Infection Control by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 48. Market Position of Players in Hospital-Acquired Infection Control, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 49. Head Office of Key Hospital-Acquired Infection Control Players
    Table 50. Hospital-Acquired Infection Control Market: Company Product Type Footprint
    Table 51. Hospital-Acquired Infection Control Market: Company Product Application Footprint
    Table 52. Hospital-Acquired Infection Control New Market Entrants and Barriers to Market Entry
    Table 53. Hospital-Acquired Infection Control Mergers, Acquisition, Agreements, and Collaborations
    Table 54. Global Hospital-Acquired Infection Control Consumption Value (USD Million) by Type (2019-2024)
    Table 55. Global Hospital-Acquired Infection Control Consumption Value Share by Type (2019-2024)
    Table 56. Global Hospital-Acquired Infection Control Consumption Value Forecast by Type (2025-2030)
    Table 57. Global Hospital-Acquired Infection Control Consumption Value by Application (2019-2024)
    Table 58. Global Hospital-Acquired Infection Control Consumption Value Forecast by Application (2025-2030)
    Table 59. North America Hospital-Acquired Infection Control Consumption Value by Type (2019-2024) & (USD Million)
    Table 60. North America Hospital-Acquired Infection Control Consumption Value by Type (2025-2030) & (USD Million)
    Table 61. North America Hospital-Acquired Infection Control Consumption Value by Application (2019-2024) & (USD Million)
    Table 62. North America Hospital-Acquired Infection Control Consumption Value by Application (2025-2030) & (USD Million)
    Table 63. North America Hospital-Acquired Infection Control Consumption Value by Country (2019-2024) & (USD Million)
    Table 64. North America Hospital-Acquired Infection Control Consumption Value by Country (2025-2030) & (USD Million)
    Table 65. Europe Hospital-Acquired Infection Control Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Europe Hospital-Acquired Infection Control Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Europe Hospital-Acquired Infection Control Consumption Value by Application (2019-2024) & (USD Million)
    Table 68. Europe Hospital-Acquired Infection Control Consumption Value by Application (2025-2030) & (USD Million)
    Table 69. Europe Hospital-Acquired Infection Control Consumption Value by Country (2019-2024) & (USD Million)
    Table 70. Europe Hospital-Acquired Infection Control Consumption Value by Country (2025-2030) & (USD Million)
    Table 71. Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Type (2019-2024) & (USD Million)
    Table 72. Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Type (2025-2030) & (USD Million)
    Table 73. Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Application (2019-2024) & (USD Million)
    Table 74. Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Application (2025-2030) & (USD Million)
    Table 75. Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Region (2019-2024) & (USD Million)
    Table 76. Asia-Pacific Hospital-Acquired Infection Control Consumption Value by Region (2025-2030) & (USD Million)
    Table 77. South America Hospital-Acquired Infection Control Consumption Value by Type (2019-2024) & (USD Million)
    Table 78. South America Hospital-Acquired Infection Control Consumption Value by Type (2025-2030) & (USD Million)
    Table 79. South America Hospital-Acquired Infection Control Consumption Value by Application (2019-2024) & (USD Million)
    Table 80. South America Hospital-Acquired Infection Control Consumption Value by Application (2025-2030) & (USD Million)
    Table 81. South America Hospital-Acquired Infection Control Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. South America Hospital-Acquired Infection Control Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Type (2019-2024) & (USD Million)
    Table 84. Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Type (2025-2030) & (USD Million)
    Table 85. Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Application (2019-2024) & (USD Million)
    Table 86. Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Application (2025-2030) & (USD Million)
    Table 87. Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Country (2019-2024) & (USD Million)
    Table 88. Middle East & Africa Hospital-Acquired Infection Control Consumption Value by Country (2025-2030) & (USD Million)
    Table 89. Hospital-Acquired Infection Control Raw Material
    Table 90. Key Suppliers of Hospital-Acquired Infection Control Raw Materials
List of Figures
    Figure 1. Hospital-Acquired Infection Control Picture
    Figure 2. Global Hospital-Acquired Infection Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Hospital-Acquired Infection Control Consumption Value Market Share by Type in 2023
    Figure 4. Catheter-associated Urinary Tract Infections (CAUTIs)
    Figure 5. Surgical Site Infections (SSIs)
    Figure 6. Central Line-associated Bloodstream Infections (CLABSIs)
    Figure 7. Respiratory Infections
    Figure 8. Global Hospital-Acquired Infection Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 9. Hospital-Acquired Infection Control Consumption Value Market Share by Application in 2023
    Figure 10. Hospitals and ICUs Picture
    Figure 11. Outpatient Care Centers Picture
    Figure 12. Long-term Care Facilities (LTCFs) Picture
    Figure 13. Global Hospital-Acquired Infection Control Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Hospital-Acquired Infection Control Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Hospital-Acquired Infection Control Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Hospital-Acquired Infection Control Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Hospital-Acquired Infection Control Consumption Value Market Share by Region in 2023
    Figure 18. North America Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Hospital-Acquired Infection Control Revenue Share by Players in 2023
    Figure 24. Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Hospital-Acquired Infection Control Market Share in 2023
    Figure 26. Global Top 6 Players Hospital-Acquired Infection Control Market Share in 2023
    Figure 27. Global Hospital-Acquired Infection Control Consumption Value Share by Type (2019-2024)
    Figure 28. Global Hospital-Acquired Infection Control Market Share Forecast by Type (2025-2030)
    Figure 29. Global Hospital-Acquired Infection Control Consumption Value Share by Application (2019-2024)
    Figure 30. Global Hospital-Acquired Infection Control Market Share Forecast by Application (2025-2030)
    Figure 31. North America Hospital-Acquired Infection Control Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Hospital-Acquired Infection Control Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Hospital-Acquired Infection Control Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Hospital-Acquired Infection Control Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Hospital-Acquired Infection Control Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Hospital-Acquired Infection Control Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Hospital-Acquired Infection Control Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Hospital-Acquired Infection Control Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Hospital-Acquired Infection Control Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Hospital-Acquired Infection Control Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Hospital-Acquired Infection Control Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Hospital-Acquired Infection Control Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Hospital-Acquired Infection Control Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Hospital-Acquired Infection Control Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Hospital-Acquired Infection Control Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Hospital-Acquired Infection Control Consumption Value (2019-2030) & (USD Million)
    Figure 65. Hospital-Acquired Infection Control Market Drivers
    Figure 66. Hospital-Acquired Infection Control Market Restraints
    Figure 67. Hospital-Acquired Infection Control Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Hospital-Acquired Infection Control in 2023
    Figure 70. Manufacturing Process Analysis of Hospital-Acquired Infection Control
    Figure 71. Hospital-Acquired Infection Control Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group